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ABSTRACT 
Present work involve study of the toxicity and the antitrypanosomal activity of the hemi syntheses (total of thiosemicarbazones) 
extracted from the substrates (reagents of thiosemicarbazides) in 1N hydrochloric acid medium from Mitracarpus Scaber 
harvested in the region of Abomey-calavi. The ethanolic, dichloromethane and hydroethanol extracts (50:50 v/v) yielded the 
alkaloid extracts with yields of 4.44%, 2.48% and 5.08% respectively leading to three products of hemi-synthesis P1, P2 and P3 
whose larval toxicities have respective values LC50: 78.1μg/mL, 95μg/mL, and 48.8 μg/mL whereas the toxicity tests of the 
alkaloid samples of ethanol, dichloromethane and hydroethanolic E1, E2 and E3 extracted from the evaluation of the same larval 
toxicity test gave values of 83.41μg/mL 102.51μg/mL and 52.91μg/mL respectively. These results were less toxic than those of 
semisynthetic products. Acute and sub-acute toxicity in non-pregnant NMRI female mice after oral gavage of P2 product has been 
shown to be non-toxic. The antitrypanosomal test was carried out according to the Alamar blue method, it revealed that P1 
moderately inhibits trypanosome parasites (IC50=18.06 μg/mL) as well as P2 and P3 with a respective IC50 of 17.24 μg/mL and 20, 
68 μg/mL while the alkaloid totals had lower antitrypanosomal activity than the hemi-synthesis products. 
Keywords: Antitrypanosomal, hemi synthesis, Mitracarpus scaber, thiosemicarbazide, toxicities. 
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INTRODUCTION 
Toxicological studies conducted on 
thiosemicarbazones do not mention their aggressivity 
in the stomach and intestinal walls. The 
pharmacokinetics and clinical phase I trials of a 
compound of thiosemicarbazones (3-aminopyridine-2-
carboxaldehyde thiosemicarbazone) 3-AP by 
intravenous injection were studied. It appeared that the 
molecule induced no toxic effect even after injection of 
a high dose. Herbal medicine referred to a practice of 
medicine that used the medicinal properties of plants
1
. 
However, in the industrialized countries, this practice 
was rarely encountered in favor of the industrial 
synthesis of molecules. We can see several reasons: 
The quantities of active substances were in very small 
quantities in the plants. At the scale of a population, 
this would require huge amounts of plants; the 
synthesis was cheaper
2
. The active molecules were 
often mixed in the plants with other undesired 
substances, and the separation was not easy and some 
natural molecules have side effects. A chemical 
synthesis consists of making a new molecule from one 
or more chemical reactions. The challenge of a 
synthesis was to start with molecules that were easy to 
obtain (inexpensive), with the highest possible yield, 
which includes the energy, invested (heating). The 
possible harmfulness/toxicity of certain reagents, 
intermediate products or reaction by-products must 
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also be taken into account. Finally, it was necessary to 
provide for the extraction and purification of the 
molecule to be synthesized. A hemi synthesis was a 
special case of chemical synthesis. The starting 
molecule was directly derived from natural substances 
and corresponds almost in its structure to the molecule 
that one wishes to produce. The challenge of a hemi-
synthesis was a slight modification in order to acquire 
the molecule or get properties it did not have, or make 
it more assimilable for a consumer. The interest 
compared to a synthesis was to save steps in the 
manufacture.  
Biologically active molecules (drugs) derive their 
properties from their structure, but also from the 
organic functions they possess
2,3,4
. For example, the 
hemi synthesis of aspirin leading to salicylic acid 
which is a molecule naturally present in the willow (a 
tree) or in the queen of the near (a plant). It has 
analgesic (pain suppressing), antipyretic (fever 
fighting) and antiseptic properties (kills bacteria and 
viruses). However, by semi synthesis from salicylic 
acid, acetylsalicylic acid, better known as aspirin, was 
produced. Indeed, it was more effective as a drug, has 
anti-inflammatory properties, and was less harmful to 
the stomach. It retains the properties of salicylic acid, 
except the antiseptic effect. Aspirin can be produced by 
reaction of salicylic acid with ethanolic acid, also 
called acetic acid. However, the yield of this reaction 
was limited to 8%. In order to increase it, it was 
possible to replace the ethanolic acid with more 
reactive ethanolic anhydride. In modern medicine most 
of the drug alternatives come from complex molecules 
found in the nature of known properties and these 
molecules are often the source of other improved 
molecules whose spectra of action have been enlarged 
compared to those of the beginning and presenting 
diminished side effects. This work was part of the 
improvement of the biological properties of the 
bioactive products of the plant Mitracarpus Scaber 
from the hybrids obtained by hemi synthesis, from 
which the knowledge of the toxic properties of the 
extracts prepared from the plant proved indispensable
5
. 
 
MATERIALS AND METHODS 
Plant material 
Fresh samples of Mitracarpus scaber were harvested 
and identified as No AA. 6252/HLB at the National 
Herbarium of the University of Abomey-Calavi
6
. The 
aerial part of the plant was cut out and dried for 10 to 
14 days in the dark, then reduced to powder using an 
electric grinder (MILLS of Nigeria Flour, El. MOTOR 
No. 1827) then the ground material was preserved until 
use. The brine shrimp larvae (Artemia salina, LEACH) 
marketed by the German firm JBL GmbH and Co.KG 
were used for the preliminary toxicity test. 
Biological material 
The brine shrimp larvae (Artemia salina, LEACH) 
marketed by the German firm JBL GmbH and Co.KG 
were used for the preliminary toxicity test Non-
pregnant NMRI female mice at 8 and 12 weeks of age 
weighing 30.8±3.8g were used for the acute and sub 
acute toxicity tests. They are maintained under 
standard conditions in the animal facility: temperature 
21±2°C, circadian rhythm day-night 12h-12h with free 
access to water and food. The relative humidity was 
maintained between 50 and 70% except during the 
cleaning of the room. The animals are kept in 110 cm x 
50 cmx20 cm wire mesh cages equipped with small 
feeders and drinking troughs. The bottom of the cages 
was constituted by a system of removable drawer 
garnished with chips of wood gathering the feces and 
the urine. Mice have free access to drinking water and 
food. They were supplied with drinking tap water and 
their diet was made of a mixture of nutrients in the 
form of croquettes.  
Preparation of raw extracts 
The maceration method in accordance with the 
traditional method of preparation was used
7
. In this 
study, three types of dichloromethanolic, 
hydroethanolic and ethanolic extracts were prepared 
for each of the 03 products; it was a total of
9
 extracts 
preserving heat-sensitive compounds and representing 
a common route of extraction in medicine traditional. 
One hundred grams (100g) of powder were mixed with 
five hundred milliliters (500mL) of solvent 
(dichloromethane, hydroethanol (50:50 v/v) or ethanol 
95°C) depending on the type of extract. The mixture is 
stirred continuously for 72 hours and filtered; this 
filtrate was then evaporated with a rotavapor (Heidolph 
Laborota 4000 efficient) coupled to cooler (Julabo FL 
300) water at 40°C and then oven dried at 40°C. The 
dry residue obtained was weighed in order to determine 
the yield according to the relation: 
Yield % =
Mass of dry extract obtained (g)
Initial mass of powder (g)
x100 
Preparation of crude Hemi extracts in situ synthesis 
of thiosemicarbazones 
0.175 g of each crude and alkaloid extract was 
dissolved in 15 ml of 95° ethanol (SIGMA-ALDRCH) 
in an Erlenmeyer flask. In another Erlenmeyer flask 
containing 5 ml of the 1N hydrochloric acid solution 
(R.P. PROLABO), 1.82g of thiosemicarbazide 
(SIGMA-ALDRCH) were dissolved and stirred gently 
until complete dissolution The contents of the 
Erlenmeyer flasks were then mixed in a 100 ml flask 
kept on a non-heating magnetic stirrer (BIOBLOCK 
AM 3000 D). The reaction was allowed to continue for 
45 to 60 minutes (or even 2 hours). After the filtration 
of the heterogeneous mixture, the crystals obtained 
were dried and recrystallized in ethanol at 95°C. 
Larval toxicity test 
The test was carried out against Artemia salina Leach 
by the method as followed by
8 
and has proposed in the 
literature as a simple biological assay method for the 
evaluation of the preliminary toxicity of active natural 
products. The eggs of Artenia salina were incubated in 
seawater until hatching of the young larvae (48 hours). 
Then, a series of solutions of each crude extract tested 
at different concentrations and gradual were prepared. 
A defined number of larvae (16) were introduced into 
each solution. All solutions and the control solution 
containing no active substance were left stirring for 24 
hours. Microscopic counting of the number of dead 
larvae in each solution was used to evaluate the toxicity 
of the solution. In the case, where there were dead 
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larvae in the control medium, the data were corrected 
by the Abbott formula: 
% Death =
Test− Control
Control
x100 
The data are transformed by logarithm and the LC50 
was determined by linear regression. Trials were 
performed in triplicate.  
Acute or sub-acute toxicity test 
The method used here was based on OECD 
recommendations
8
. We carried out a limit test 
consisting of a sequential test using 3 female mice per 
step. They were fasted for 12 hours before a single 
dose by oral gavage of 2000 mg/kg. The animals were 
observed closely for the first 4 hours in search of 
toxicity symptoms and the survival rate was evaluated 
after 24 hours. The animals will remain under 
observation for the next 14 days. If no mortality was 
observed at the end of this first step, a second 
confirmation test was performed.  
This procedure, adapted to traditional preparations with 
proven ethno evidence, allows the determination of an 
approximate LD50 using a minimum of animals. It was 
carried out in an approach that combines the work of 
9
 
with those of
10
 Two groups of 06 mice were 
constituted. The group 1 (control group) receives 
physiological saline for 14 days and group 2 (treated 
group) receives the test extract in per os daily also for 
14 days at a dose of 1000 mg/kg body weight. The 
mice weighed daily will all be sacrificed on the 
fifteenth day and their main organs (heart, lung, 
kidney, liver, stomach and spleen) will be removed 
after dissection and weighed.  
Statistical treatment of data 
The analysis of the data collected during the survey 
was carried out on the basis of the descriptive statistics 
using "MICROSOFT EXCEL 2013" highlighting the 
percentages of the respondents in relation to the total 
number of respondents. This analysis was followed by 
a taxonomic identification of plant species identified at 
two levels. For the first level of identification, local 
names of plant species were compared to scientific 
names reported in the literature. A second level of 
identification was carried out at the laboratory of the 
National Herbarium of Benin where the scientific 
names of the plant species identified in the literature 
were confirmed.  
In vitro antitrypanosomal test 
This test was carried out according to the method 
described by Ganfon et al.
11
 and Räz et al.
12
 and 
recently used by Brun et al.
13
. Trypanosomes were 
diluted to adequate cell density. The cell density was 
adapted so that after 72 hours of incubation in the 
control wells, the cells were at the end of the 
logarithmic growth phase (Trypanosoma brucei: 5x104 
tryps/ml). The density of trypanosomes was adjusted 
by a counting device: the hemocytometer. Per plate, 
2ml of trypanosome stock will be used. 50 μl of the 
medium at room temperature were added to each well 
except for the extreme wells and column 11 (columns 2 
to 10 in row B to G). 75 μL of medium containing 
twice the highest concentration of compounds (stock 
solution II) were placed in the wells of column 11 to be 
tested (compound No. 1 in rows B, C, D and compound 
No. 2 in rows E, F, G). Three dilution series were 
prepared with a multi pipette (6 channels are needed). 
Volume of 25 μl of the 6 wells of column 11 are taken 
and then transferred to column 10. The mixture was 
subsequently stirred.  
The dilution from right to left was continued until 
addition of 25 μl of column 5 to column 4. After 
mixing, the remaining 25 μL are removed (total 
volume in each well equal to 50 μL at this stage). The 
wells in columns 2 and 3 serve as control wells 
(without addition of compound). 50 μl of trypanosome 
suspension were added to the wells of rows C, D, E, F 
of columns 2 to 11; then 50 μL of medium without 
trypanosome in rows B and G of the same columns. 
These wells serve as blank control. After incubation for 
72 hours at 37°C, with 5% CO2, the plates were 
observed under an inverted microscope to determine 
MIC (minimum inhibitory concentration): the lowest 
concentration of compounds to which no trypanosomes 
with normal morphology and motility compared to 
control well cannot be observed. Additional 
information may be recorded such as insolubility of the 
compound, microbial contamination, etc. 10 μl of 
Alamar Blue Fluorescent Dye, which can be diluted 1: 
1 in phosphate buffered saline and incubated for a 
further 4 hours at 37°C, were added to each well. The 
plate was read with a fluorescence plate reader at an 
excitation wavelength of 530 nm and an emission 
wavelength of 590 nm. The data can be transferred into 
a graphics program (Excel) and the IC50 values can be 
evaluated by linear interpolation (Excel sheet 
template). 
 
RESULTS AND DISCUSSION 
Yield of extractions 
The yield of the extracts obtained is expressed as a 
percentage of dry extract contained in 100 g of powder 
of the plant. The values obtained are summarized in 
Table 1. 
It can be seen from this table that the best yield was 
obtained with the crude hydroethanolic extract; which 
means that most of the chemical principles of the plant 
are polar. The same observation was made at the level 
of the corresponding total alkaloid extracts. It can 
therefore be deduced that the yield of the total alkaloids 
was closely related to that of the parent crude extracts. 
On the other hand, yields were more or less improved 
compared to previous work
14,15
. This allows us to say 
that the yields of extractions often depend on the type 
of extraction performed. Depending on whether fresh 
plant material was passed to dry plant material, yield 
can vary significantly
16
. This yield therefore depends 
enormously on the state of the plant material.  
Products P1, P2 and P3 indicated the respective LC50 
values of 78.1 μg/mL, 97.5 μg/mL and 48.8 μg/mL 
during these toxicity tests, while alkaloid extracts E1, 
E2 and E3 were 83.41μg/mL, 102.51μg/mL, and 
52.91μg/mL sources of semisynthetic products P1, P2 
and P3. All the matrices tested each have an LC50 value 
of greater than 30 μg/ml. According to the literature, 
they were not very toxic
17
 with a tendency for alkaloid 
extracts to be less toxic than those of semi synthetic 
products. In order to assess the degree of toxicity of the 
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extracts from the LC50 values, we conform to the 
correspondence (Table 3) established by
18,19
. When the 
CL50 was greater than or equal to 100 μg/mL, the 
extract was nontoxic. An LC50 between 50 μg/mL and 
100 μg/mL indicates low toxicity while an LC50 
between 10 μg/mL and 50 μg/mL gives a moderate 
toxicity. An CL50 less than 10 μg/mL gives the extract 
a high toxicity: 
Analysis of the CL50 values of the extracts tested with 
respect to the correspondence table above, allows us to 
say that the products of hemi ethanolic synthesis more 
active and less toxic in the range of concentrations 
analyzed, because the CL50 obtained were within the 
fixed limits (100 μg/mL> CL50≥50 μg/mL). The values 
of the IS (Table 2), taking into account the values of 
the CL50 and CI50, show that all products used in 
current study were selective and that the semisynthetic 
product P2 was more selective (IS=5.65) than P1 and 
P3
21,20
. The P2 thiosemicarbazone extract was first 
subjected to the cytotoxicity test on WI-38 cells 
(human embryonic fibroblasts). For this test, the result 
was expressed by the half-inhibitory concentration 
(CI50) which was greater than 100 μg/mL for the 
ethanol extract against 0.4 ± 0.2 μg/mL for the control 
(tetracycline). The CI50 was equal to 50 μg/ml for the 
half-synthetic product P2. Since the toxicity limit was 
set at 20 μg / mL10,22 it can be concluded that P2 was 
not harmful to WI-38 cells. This result reinforces that 
of the larval toxicity which has previously made it 
possible to demonstrate the non-toxic nature of the P2 
extract on shrimp larvae and consequently on the 
human cells of carcinoma and colon in reference to the 
previous work
23,24
.  
Acute toxicity 
At the end of the acute toxicity study, mice given the 
P2 extract administered at a dose of 2000 mg / kg body 
weight showed no toxic symptoms and no deaths were 
observed. These results make it possible to locate the 
LD50 for the extract above 2 g/kg of body weight. 
According to the OECD
8
 a substance with an LD50≥2 
g/kg was classified in category 5 grouping very low-
toxicity substances. 
Sub-acute toxicity 
In the sub-acute toxicity study, daily administration of 
a 1000 mg/kg body weight dose of P2 resulted in no 
deaths at the end of the treatment period. Changes in 
body mass showed no significant weight gain in both 
the control and treated groups. It can therefore be 
concluded that the extracts have no significant effect 
on weight gain
25
 (Figure 1). 
Comparison of organ masses (heart, lung, liver, 
kidneys, and spleen) and body mass between treated 
and control groups showed no significant difference. 
Macroscopic observation of these organs revealed no 
increase in volume, nor congestion, lesion or necrosis. 
These results reinforce the need for the use of certain 
plants in Traditional Medicine without risk of 
intoxication in order to enrich the therapeutic arsenal of 
modern medicine
26
. 
Antitrypanosomal activity of the extracts 
The antitrypanosomal test performed according to the 
Alamar blue protocol, revealed that P1 moderately 
inhibits trypanosome parasites (CI50=18.06 μg/mL) as 
well as P2 and P3 with CI50 of 17.24μg/mL and 20.68 
μg/mL, whereas alkaloid totals showed lower 
antitrypanosomal activity than semi synthetic products 
(Table 2).  
It was important to remember that pest control tests 
were never performed from samples of present study; 
what makes this work, its originality in the search for 
trypanocidal molecules
27
. 
E1, E2 and E3: Total alkaloids from the hydroethanol, 
ethanol and dichloromethane extracts. P1, P2 and P3 
respectively denote the semi synthesis products from 
these total alkaloids. The analysis of Table 4 shows 
that the hemi-synthesis was beneficial to the biological 
activity of the alkaloidal totals which have seen their 
antiparasitic activity which was initially weak 
increased one can conclude that this work brings a 
more in the fight against this formidable disease what 
was trypanosomosis. However, data concerning the 
toxicity of P1, P2 and P3 products were fundamental 
for a better appreciation of this activity.  
 
CONCLUSION 
The shrimp larvae were tolerant of ethanolic, 
dichloromethane and hydroethanolic extracts and 
therefore the leafy stems of the plant do not have a 
priori harmful effects on human cells 9 PS, 9 KB, A-
549 and HT-29.  
This preliminary study contributes to the valorization 
of the Beninese flora and deserves to be deepened by 
evaluating the anti-trypanocidal power of extracts and 
by quantifying the chemical groups proven to be 
responsible for this activity. In addition, the in vivo 
toxicity tests have shown that the extract was not 
harmful inside the body. The non-toxic nature of this 
extract, supported by the demonstrated 
antitrypanosomal activities, was a reason for further 
investigation of the P2 extract in order to purify and 
then isolate active molecules. In view of the 
importance of thiosemicarbazones in the field of health 
on the one hand and of these biological potentialities, it 
would be beneficial to continue investigations on the 
plant by exploring other lines of research. and it is in 
this context that the present work is inscribed. 
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Table1: Returns of the different extracts 
Type of extract Yield (%) 
Ethanolic Gross 19.23 
alkaloid 4.44 
Dichloromethane Gross 16.13 
alkaloid 2.48 
Hydro-ethanolic 
(50:50, V / V) 
Gross 21.09 
alkaloid 5.08 
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Table 2: Pharmacological Properties of P1, P2, P3. 
Products CL50 (µg/mL) CI50 (µg/mL)  IS 
P1 78.1 18.08 4.39 
P2 97.5 17.24 5.65 
P3 48.8 20.68 2.35 
 
 
Table 3: Correspondence between LC50 and toxicity 
CL50 Toxicity 
CL50 ≥ 100 µg/mL  - 
100 µg/mL > CL50 ≥ 
50 µg/mL  
+ 
50 µg/mL > CL50 ≥ 
10 µg/mL  
+ + 
CL50 < 10 µg/mL  + + + 
- : non toxic; +: low toxicity; ++: moderate toxicity; +++: high toxicity 
 
 
Figure 1: Evolution of body mass in % at the end of the treatment period 
 
 
Table 4: Values of CI50 inhibitory half-concentrations 
Products CI50 (µg/mL) 
E1 40.16 
E2 38.70 
E3 46.19 
P1 18.08 
P2 17.24 
P3 20.68 
 
 
 
 
